Sanofi pipeline：R&D Focus Areas
R&D Focus Areas
AsofJuly28,2023,ourR&Dpipelineincludes78clinical-stageprojects,23ofwhichareinphase3orhavebeensubmittedtoregulatoryauthoritiesfor ...。其他文章還包含有：「ImmunologyandInflammation」、「OncologyR&D」、「OurHealthcarePipeline」、「PR」、「PR」、「Sanofipipeline」、「Sanofi'sProgressinBuildingaDiverseEarlyOncology...」、「Sanofi」
查看更多 離開網站
Immunology and Inflammation
https://www.sanofi.com
Sanofi has a robust pipeline of potential new medicines for chronic dermatologic, respiratory, and gastrointestinal diseases.
Oncology R&D
https://www.sanofi.com
Sanofi's oncology pipeline focuses on four diseases areas: multiple myeloma and other blood cancers, skin cancers, lung cancers, and breast cancer and other ...
Our Healthcare Pipeline
https://www.sanofi.com
Discover Sanofi's R&D portfolio and its various projects aimed at improving the lives of patients and contributing to public health.
PR
https://www.sanofi.com
Sanofi now expects 2023 business EPS(1) to grow mid single-digit(2) at CER, barring unforeseen major adverse events. Applying average July 2023 ...
PR
https://www.sanofi.com
Today Sanofi is hosting a Vaccines Investor Event dedicated to its pipeline with key members of its leadership team.
Sanofi pipeline
https://www.sanofi.com
With a strong focus on difficult-to-treat diseases and immunization, our R&D pipeline includes 78 clinical-stage projects, 24 of which are in ...
Sanofi's Progress in Building a Diverse Early Oncology ...
https://www.sanofi.com
Over the past few years, Sanofi has significantly strengthened its commitment to oncology, building a differentiated pipeline and focusing ...
Sanofi
https://www.sanofi.com
Partner Spotlight: miRecule and Sanofi drive the emergence of RNA therapeutics for ... Press Release: Solid Q2 performance and strong pipeline momentum, ...